Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation

Amanda R. Harrington, Edward P. Armstrong, Paul E. Nolan, Daniel C. Malone

Research output: Contribution to journalArticlepeer-review

186 Scopus citations

Fingerprint Dive into the research topics of 'Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation'. Together they form a unique fingerprint.

Medicine & Life Sciences